Lorence H. Kim
CIK 1643746 · View on SEC EDGAR ↗
First SEC filing: Oct. 7, 2022 · Latest: March 1, 2023
On this page
- Insider at Companies where this person is a reporting insider.
- Insider transactions Every share this person bought or sold, from Form 4 filings.
- Derivatives Options and other derivative holdings reported by this person.
- Initial holdings The stakes this person held when they first started reporting.
- Compensation Executive pay disclosed in company proxy statements.
Insider at
Insider transactions
Price change vs current quote, split-adjusted for corporate actions since the filing — not benchmarked, not annualized, not size-weighted
| Date | Ticker | Code | Shares | Price | Value | Owned after | Δ own | A/D | vs now |
|---|---|---|---|---|---|---|---|---|---|
| Feb. 25, 2022 | 1466538 | P | 30,000 | $30.03 | $900,900 | 30,000 Direct | — | Acquired | |
| June 2, 2020 | MRNA | S 10b5-1 | 241,000 | $58.30 | $14,050,300 | 1,202,510 Direct | -16.70% | Disposed | 145.7% (price as of 2026-08-20) |
| May 27, 2020 | MRNA | S 10b5-1 | 241,000 | $51.13 | $12,322,330 | 1,202,510 Direct | -16.70% | Disposed | 180.1% (price as of 2026-08-20) |
| May 18, 2020 | MRNA | S 10b5-1 | 798 | $86.96 | $69,394 | 1,202,510 Direct | -0.07% | Disposed | 64.7% (price as of 2026-08-20) |
| May 18, 2020 | MRNA | S 10b5-1 | 2,600 | $86.54 | $225,004 | 1,203,308 Direct | -0.22% | Disposed | 65.5% (price as of 2026-08-20) |
| May 18, 2020 | MRNA | S 10b5-1 | 5,868 | $85.16 | $499,719 | 1,205,908 Direct | -0.48% | Disposed | 68.2% (price as of 2026-08-20) |
| May 18, 2020 | MRNA | S 10b5-1 | 33,792 | $84.27 | $2,847,652 | 1,211,776 Direct | -2.71% | Disposed | 70.0% (price as of 2026-08-20) |
| May 18, 2020 | MRNA | S 10b5-1 | 59,175 | $83.33 | $4,931,053 | 1,245,568 Direct | -4.54% | Disposed | 71.9% (price as of 2026-08-20) |
| May 18, 2020 | MRNA | S 10b5-1 | 56,379 | $82.28 | $4,638,864 | 1,304,743 Direct | -4.14% | Disposed | 74.1% (price as of 2026-08-20) |
| May 18, 2020 | MRNA | S 10b5-1 | 16,736 | $81.43 | $1,362,812 | 1,361,122 Direct | -1.21% | Disposed | 75.9% (price as of 2026-08-20) |
| May 18, 2020 | MRNA | S 10b5-1 | 35,569 | $80.24 | $2,854,057 | 1,377,858 Direct | -2.52% | Disposed | 78.5% (price as of 2026-08-20) |
| May 18, 2020 | MRNA | S 10b5-1 | 18,675 | $79.40 | $1,482,795 | 1,413,427 Direct | -1.30% | Disposed | 80.4% (price as of 2026-08-20) |
| May 18, 2020 | MRNA | S 10b5-1 | 7,640 | $77.48 | $591,947 | 1,432,102 Direct | -0.53% | Disposed | 84.9% (price as of 2026-08-20) |
| May 18, 2020 | MRNA | S 10b5-1 | 3,768 | $76.45 | $288,064 | 1,439,742 Direct | -0.26% | Disposed | 87.4% (price as of 2026-08-20) |
| May 15, 2020 | MRNA | S 10b5-1 | 2,600 | $63.80 | $165,880 | 1,219,910 Direct | -0.21% | Disposed | 124.5% (price as of 2026-08-20) |
| May 15, 2020 | MRNA | S 10b5-1 | 2,243 | $66.68 | $149,563 | 1,202,510 Direct | -0.19% | Disposed | 114.8% (price as of 2026-08-20) |
| May 15, 2020 | MRNA | S 10b5-1 | 9,715 | $66.05 | $641,676 | 1,204,753 Direct | -0.80% | Disposed | 116.9% (price as of 2026-08-20) |
| May 15, 2020 | MRNA | S 10b5-1 | 5,442 | $64.96 | $353,512 | 1,214,468 Direct | -0.45% | Disposed | 120.5% (price as of 2026-08-20) |
| May 15, 2020 | MRNA | S 10b5-1 | 2,600 | $63.80 | $165,880 | 1,219,910 Direct | -0.21% | Disposed | 124.5% (price as of 2026-08-20) |
| May 12, 2020 | MRNA | S 10b5-1 | 2,237 | $67.32 | $150,595 | 1,222,510 Direct | -0.18% | Disposed | 112.8% (price as of 2026-08-20) |
| May 12, 2020 | MRNA | S 10b5-1 | 5,677 | $66.43 | $377,123 | 1,224,747 Direct | -0.46% | Disposed | 115.6% (price as of 2026-08-20) |
| May 12, 2020 | MRNA | S 10b5-1 | 61,412 | $65.47 | $4,020,644 | 1,230,424 Direct | -4.75% | Disposed | 118.8% (price as of 2026-08-20) |
| May 12, 2020 | MRNA | S 10b5-1 | 104,544 | $64.67 | $6,760,860 | 1,291,836 Direct | -7.49% | Disposed | 121.5% (price as of 2026-08-20) |
| May 12, 2020 | MRNA | S 10b5-1 | 31,948 | $63.57 | $2,030,934 | 1,396,380 Direct | -2.24% | Disposed | 125.3% (price as of 2026-08-20) |
| May 12, 2020 | MRNA | S 10b5-1 | 35,182 | $62.56 | $2,200,986 | 1,428,328 Direct | -2.40% | Disposed | 129.0% (price as of 2026-08-20) |
| April 15, 2020 | MRNA | S 10b5-1 | 400 | $38.24 | $15,296 | 1,222,510 Direct | -0.03% | Disposed | 274.6% (price as of 2026-08-20) |
| April 15, 2020 | MRNA | S 10b5-1 | 7,340 | $37.62 | $276,131 | 1,222,910 Direct | -0.60% | Disposed | 280.7% (price as of 2026-08-20) |
| April 15, 2020 | MRNA | S 10b5-1 | 4,566 | $36.57 | $166,979 | 1,230,250 Direct | -0.37% | Disposed | 291.7% (price as of 2026-08-20) |
| April 15, 2020 | MRNA | S 10b5-1 | 1,517 | $35.81 | $54,324 | 1,234,816 Direct | -0.12% | Disposed | 300.0% (price as of 2026-08-20) |
| April 15, 2020 | MRNA | S 10b5-1 | 6,177 | $34.24 | $211,500 | 1,236,333 Direct | -0.50% | Disposed | 318.3% (price as of 2026-08-20) |
| March 16, 2020 | MRNA | S 10b5-1 | 1,134 | $27.39 | $31,060 | 1,242,510 Direct | -0.09% | Disposed | 422.9% (price as of 2026-08-20) |
| March 16, 2020 | MRNA | S 10b5-1 | 9,370 | $26.74 | $250,554 | 1,243,644 Direct | -0.75% | Disposed | 435.7% (price as of 2026-08-20) |
| March 16, 2020 | MRNA | S 10b5-1 | 6,704 | $25.85 | $173,298 | 1,253,014 Direct | -0.53% | Disposed | 454.1% (price as of 2026-08-20) |
| March 16, 2020 | MRNA | S 10b5-1 | 2,792 | $24.68 | $68,907 | 1,259,718 Direct | -0.22% | Disposed | 480.4% (price as of 2026-08-20) |
| March 4, 2020 | MRNA | S 10b5-1 | 20,000 | $27.71 | $554,200 | 1,262,510 Direct | -1.56% | Disposed | 416.9% (price as of 2026-08-20) |
| Feb. 26, 2020 | MRNA | S 10b5-1 | 745 | $29.46 | $21,948 | 1,282,510 Direct | -0.06% | Disposed | 386.2% (price as of 2026-08-20) |
| Feb. 26, 2020 | MRNA | S 10b5-1 | 12,819 | $28.79 | $369,059 | 1,283,255 Direct | -0.99% | Disposed | 397.5% (price as of 2026-08-20) |
| Feb. 26, 2020 | MRNA | S 10b5-1 | 5,088 | $27.96 | $142,260 | 1,296,074 Direct | -0.39% | Disposed | 412.3% (price as of 2026-08-20) |
| Feb. 25, 2020 | MRNA | S 10b5-1 | 100 | $26.14 | $2,614 | 1,301,162 Direct | -0.01% | Disposed | 448.0% (price as of 2026-08-20) |
| Feb. 25, 2020 | MRNA | S 10b5-1 | 1,248 | $25.59 | $31,936 | 1,301,262 Direct | -0.10% | Disposed | 459.7% (price as of 2026-08-20) |
| Feb. 7, 2020 | MRNA | S 10b5-1 | 33,295 | $23.06 | $767,783 | 1,302,510 Direct | -2.49% | Disposed | 521.1% (price as of 2026-08-20) |
| Jan. 28, 2020 | MRNA | S 10b5-1 | 900 | $23.37 | $21,033 | 1,335,805 Direct | -0.07% | Disposed | 512.9% (price as of 2026-08-20) |
| Jan. 27, 2020 | MRNA | S 10b5-1 | 23,805 | $23.01 | $547,753 | 1,336,705 Direct | -1.75% | Disposed | 522.5% (price as of 2026-08-20) |
| Jan. 22, 2020 | MRNA | S 10b5-1 | 2,000 | $23.04 | $46,080 | 1,360,510 Direct | -0.15% | Disposed | 521.7% (price as of 2026-08-20) |
| Dec. 6, 2019 | MRNA | S 10b5-1 | 1,306 | $20.93 | $27,335 | 1,362,510 Direct | -0.10% | Disposed | 584.4% (price as of 2026-08-20) |
| Dec. 6, 2019 | MRNA | S 10b5-1 | 147,528 | $20.39 | $3,008,096 | 1,363,816 Direct | -9.76% | Disposed | 602.5% (price as of 2026-08-20) |
| Dec. 6, 2019 | MRNA | S 10b5-1 | 89,698 | $19.34 | $1,734,759 | 1,511,344 Direct | -5.60% | Disposed | 640.6% (price as of 2026-08-20) |
P = Open-market purchase · S = Sale · A = Grant/award · M = Option exercise · G = Gift · F = Tax withholding
Insider transactions are not a recommendation; sales are often driven by liquidity or tax reasons.
Derivative holdings (Form 4 Table II)
Options, RSUs and convertible securities reported on Form 4 Table II.
| Date | Ticker | Security | Underlying | Exercise price | Expiration | Shares | A/D |
|---|---|---|---|---|---|---|---|
| June 18, 2026 | RVMDW | Stock Option (Right to Buy) | Common Stock (3,127) | $162.99 | June 18, 2036 | 3,127 | Acquired |
| June 2, 2020 | MRNA | Stock Option (Right to Buy) | Common Stock (96,660) | $19.15 | Aug. 10, 2026 | 96,660 | Disposed |
| June 2, 2020 | MRNA | Stock Option (Right to Buy) | Common Stock (66,031) | $19.15 | Aug. 10, 2026 | 66,031 | Disposed |
| June 2, 2020 | MRNA | Stock Option (Right to Buy) | Common Stock (78,309) | $14.22 | Feb. 28, 2028 | 78,309 | Disposed |
| May 27, 2020 | MRNA | Stock Option (Right to Buy) | Common Stock (222,365) | $14.22 | Feb. 28, 2028 | 222,365 | Disposed |
| May 27, 2020 | MRNA | Stock Option (Right to Buy) | Common Stock (18,635) | $12.21 | Feb. 23, 2027 | 18,635 | Disposed |
| May 18, 2020 | MRNA | Stock Option (Right to Buy) | Common Stock (211,978) | $12.21 | Feb. 23, 2027 | 211,978 | Disposed |
| May 18, 2020 | MRNA | Stock Option (Right to Buy) | Common Stock (29,022) | $14.22 | Feb. 28, 2028 | 29,022 | Disposed |
| May 12, 2020 | MRNA | Stock Option (Right to Buy) | Common Stock (11,643) | $12.21 | Feb. 23, 2027 | 11,643 | Disposed |
| May 12, 2020 | MRNA | Stock Option (Right to Buy) | Common Stock (229,357) | $10.90 | Feb. 23, 2026 | 229,357 | Disposed |
| Feb. 28, 2020 | MRNA | Stock Option (Right to Buy) | Common Stock (179,022) | $25.93 | Feb. 28, 2030 | 179,022 | Acquired |
| Dec. 6, 2019 | MRNA | Restricted Stock Units | Common Stock (229,358) | $0.00 | — | 229,358 | Disposed |
| Dec. 6, 2019 | MRNA | Restricted Stock Units | Common Stock (229,357) | $0.00 | — | 229,357 | Disposed |
| June 13, 2019 | MCRB | Stock Option (right to buy) | Common Stock (15,000) | $2.83 | June 12, 2029 | 15,000 | Acquired |
| March 8, 2019 | MRNA | Stock Option (Right to Buy) | Common Stock (211,997) | $20.93 | March 8, 2029 | 211,997 | Acquired |
| Dec. 11, 2018 | MRNA | Series E Preferred Stock | Common Stock (458) | — | — | 458 | Disposed |
| June 26, 2018 | MCRB | Stock Option (right to buy) | Common Stock (15,000) | $9.09 | June 25, 2028 | 15,000 | Acquired |
| June 20, 2017 | MCRB | Stock Option (right to buy) | Common Stock (15,000) | $11.21 | June 19, 2027 | 15,000 | Acquired |
| June 15, 2016 | MCRB | Stock Option (right to buy) | Common Stock (15,000) | $30.24 | June 14, 2026 | 15,000 | Acquired |
| June 25, 2015 | MCRB | Stock Option (right to buy) | Common Stock (15,000) | $18.00 | June 24, 2025 | 15,000 | Acquired |
Exercise/conversion price is blank when not applicable (e.g. RSUs).
Initial ownership (Form 3) 16 holdings
Securities held when first becoming an insider, per SEC Form 3.
| Date | Ticker | Security | Shares | Ownership |
|---|---|---|---|---|
| Oct. 7, 2022 | COR | Common Stock | 72 | Indirect |
| Oct. 7, 2022 | COR | Common Stock | 81 | Indirect |
| Oct. 7, 2022 | COR | Common Stock | 5 | Indirect |
| Oct. 7, 2022 | COR | Common Stock | 5 | Indirect |
| Oct. 7, 2022 | COR | Common Stock | 5 | Indirect |
| Dec. 7, 2018 | MRNA | Common Stock | 1,146,869 | Direct |
| Dec. 7, 2018 | MRNA | Series E Preferred Stock→ Common Stock (458) | 458 | Direct |
| Dec. 7, 2018 | MRNA | Stock Option (Right to Buy)→ Common Stock (229,357) | 229,357 | Direct |
| Dec. 7, 2018 | MRNA | Stock Option (Right to Buy)→ Common Stock (268,029) | 268,029 | Direct |
| Dec. 7, 2018 | MRNA | Stock Option (Right to Buy)→ Common Stock (96,660) | 96,660 | Direct |
| Dec. 7, 2018 | MRNA | Stock Option (Right to Buy)→ Common Stock (644,403) | 644,403 | Direct |
| Dec. 7, 2018 | MRNA | Stock Option (Right to Buy)→ Common Stock (298,165) | 298,165 | Direct |
| Dec. 7, 2018 | MRNA | Stock Option (Right to Buy)→ Common Stock (917,431) | 917,431 | Direct |
| Dec. 7, 2018 | MRNA | Restricted Stock Units→ Common Stock (229,357) | 229,357 | Direct |
| Dec. 7, 2018 | MRNA | Restricted Stock Units→ Common Stock (229,358) | 229,358 | Direct |
| June 25, 2015 | MCRB | Stock Option (right to buy)→ Common Stock (75,000) | 75,000 | Direct |
Compensation (DEF 14A)
Matched by name from proxy statements (DEF 14A) — verify against the filing.
MRNA
CFO| Fiscal year | Salary | Bonus | Stock awards | Option awards | Non-equity incentive | Pension change | Other | Total |
|---|---|---|---|---|---|---|---|---|
| 2020 | $418,211 | $145,000 | — | $2,500,000 | — | — | $330,775 | $3,393,986 |
| 2018 | $542,769 | $450,450 | — | — | — | — | $228,386 | $9,038,117 |
Figures from the Summary Compensation Table of the company's proxy statement (DEF 14A). Compensation is not a recommendation.